Year: 2015
Type: article
Study design: Observational Study
Abstract: Background : Psoriasis is a chronic immune-inflammatory-mediated disease characterized by epidermal hyperplasia and angiogenesis. Recently, vascular endothelial growth factor receptors (VEGFRs, including VEGFR-1, VEGFR-2 and VEGFR-3) were found to be expressed in normal human epidermis and associated with proliferation and migration of keratinocytes. Objective: The purpose of this study is to investigate the serum level of vascular endothelial growth factor receptors (sVEGFR1 and sVEGFR2) in psoriatic patients Methods: 100 consenting psoriatic patients(males and females) aged 20-60 years who attended out patients clinic of dermatology in Al-Sadr Medical City in AL-Najaf city -Iraq. Psoriasis area and severity index assessment was done for each patient. Blood samples was collected for vascular endothelial growth factor receptor 1 and receptor 2 measurement . Result: The serum level of vascular endothelial growth factor receptor 1 in addition to receptor 2 were significantly increased in all group of psoriatic patients compared to healthy controls (P<0.001) . Conclusion: The serum level of vascular endothelial growth factor receptor 1 in addition to receptor 2 had significant role in evolution of psoriatic plaque. Keywords: Serum vascular endothelial growth receptor 1, Serum vascular endothelial growth receptor 2,Psoriasis area and severity index, Psoriasis. List of abbreviation: sVEGFR= serum vascular endothelial growth receptor, PASI = Psoriasis area and severity index, SD=standard deviation , ECs = endothelial cells . ELISA= Enzyme Linked Immuno Linked Sorbant Assay.
Author: Hadi Abed Hadi Al-Wakeel
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W1902063231
